rs750539692
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001318895.3(FHL2):c.509C>T(p.Thr170Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000000687 in 1,455,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001318895.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FHL2 | NM_001318895.3 | c.509C>T | p.Thr170Ile | missense_variant | Exon 6 of 7 | ENST00000530340.6 | NP_001305824.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FHL2 | ENST00000530340.6 | c.509C>T | p.Thr170Ile | missense_variant | Exon 6 of 7 | 1 | NM_001318895.3 | ENSP00000433567.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000850 AC: 2AN: 235272 AF XY: 0.0000158 show subpopulations
GnomAD4 exome AF: 6.87e-7 AC: 1AN: 1455276Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 723186 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with FHL2-related disease. This variant is present in population databases (rs750539692, ExAC 0.02%). This sequence change replaces threonine with isoleucine at codon 170 of the FHL2 protein (p.Thr170Ile). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and isoleucine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at